Alpha-Lipoic Acid (ALA) is a mitochondrial fatty acid that is highly involved in energy metabolism. It is synthesized in the body and can be consumed through eating meats and minimally in some fruits/vegetables.

ALA has shown benefit against various forms of oxidation and inflammation in supplement form. These effects carry on to benefits that protect one from heart diseases, liver diseases, diabetes, and neurological decline with age.

Alpha-lipoic acid might lower blood sugar. It is important that people with diabetes should be careful in taking it.

Rashes are likely to occur to people taking alpha-lipoic acid. People at risk for thiamine deficiency should take a thiamine supplement.


Not enough is known about the use of alpha-lipoic acid during pregnancy and breast-feeding. Stay on the safe side and avoid use.



Be cautious with this combination

Medications for cancer (Chemotherapy) interacts with ALPHA-LIPOIC ACID

Alpha-lipoic acid is an antioxidant. There is some concern that antioxidants might decrease the effectiveness of some medications used for cancers. But it is too soon to assume that this interaction really occurs.

For treating type 2 diabetes and improving symptoms such as burning, pain, and numbness in the legs and arms, a person should take 600 or 1200 mg daily.


Available brands:

  • 4G
  • Ad-C Plus
  • Gluta-White/Gluta-White 500
  • ALAnerv
  • Diamaxin

Related Articles

Vaccine, DTP

DTP vaccine (Diphtheria and Tetanus toxoids and Pertussis adsorbed vaccine) is a combination vaccine used to induce specific antibody production, thus promoting immunity [...]


Teicoplanin is a glycopeptide antibiotic drug that inhibits the growth of susceptible organisms by disrupting cell-wall synthesis. It binds to D-alanyl-D-alanine residues resulting to peptidoglycan synthesis blockage. Use this [...]


Secukinumab is a human monoclonal antibody, Immunoglobulin G1/K that binds selectively to interleukin-17A (IL-17A), a natural cytokine affecting normal inflammatory and immune responses. It inhibits the release [...]